Ibraheem Mahmood has an extensive life science and finance background that spans more than 20 years. His experience includes previous roles in Lifescience M&A and Fundraising at Nomura, Lifescience Equity Research at Investec and Business Development and Corporate Venture Capital at Shire Pharmaceuticals. He was co-founder, President and CEO of the clinical operations services company DrugDev, in which he raised over $50m in financing and he sold the business to IQVIA in 2017. Ibraheem studied medicine at the University of Oxford.